Our Biologics Discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. Our services cover recombinant DNA engineering, cell line development, hybridoma technology, next-generation sequencing, and protein sciences (purification & crystallography). Additionally, we also support integrated drug discovery for biologics with SynVent – Syngene’s platform for fully integrated therapeutic discovery and development.